374 related articles for article (PubMed ID: 23395534)
1. The clinical utility of a positive antinuclear antibody test result.
Abeles AM; Abeles M
Am J Med; 2013 Apr; 126(4):342-8. PubMed ID: 23395534
[TBL] [Abstract][Full Text] [Related]
2. Antinuclear antibody testing. A study of clinical utility.
Slater CA; Davis RB; Shmerling RH
Arch Intern Med; 1996 Jul; 156(13):1421-5. PubMed ID: 8678710
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of antinuclear antibody tests in children.
McGhee JL; Kickingbird LM; Jarvis JN
BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
[TBL] [Abstract][Full Text] [Related]
4. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Davis P
J Rheumatol; 1998 Oct; 25(10):1980-5. PubMed ID: 9779854
[TBL] [Abstract][Full Text] [Related]
5. Antinuclear antibody testing in a Turkish pediatrics clinic: is it always necessary?
Aygün E; Kelesoglu FM; Dogdu G; Ersoy A; Basbug D; Akça D; Çam ÖN; Akyüz B; Günsay T; Kapici AH; Aydin NG; Karapinar E; Atay S; Saglam N; Okumus NK; Can MZ; Yazici F; Ömeroglu RE
Pan Afr Med J; 2019; 32():181. PubMed ID: 31312295
[TBL] [Abstract][Full Text] [Related]
6. Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study.
Compagno M; Jacobsen S; Rekvig OP; Truedsson L; Heegaard NH; Nossent J; Jönsen A; Jacobsen RS; Eilertsen GØ; Sturfelt G; Bengtsson AA
Scand J Rheumatol; 2013; 42(4):311-6. PubMed ID: 23496224
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic significance of antinuclear antibodies].
Swaak AJ
Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
[TBL] [Abstract][Full Text] [Related]
8. Detection of anti-nuclear antibody by immunofluorescence assay and enzyme immunoassay in childhood systemic lupus erythematosus: experience from Bangladesh.
Dipti TR; Azam MS; Sattar MH; Rahman SA
Int J Rheum Dis; 2012 Feb; 15(1):121-5. PubMed ID: 22324956
[TBL] [Abstract][Full Text] [Related]
9. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
Homburger HA; Cahen YD; Griffiths J; Jacob GL
Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
[TBL] [Abstract][Full Text] [Related]
10. Association between antinuclear antibody titers and connective tissue diseases in a Rheumatology Department.
Menor Almagro R; Rodríguez Gutiérrez JF; Martín-Martínez MA; Rodríguez Valls MJ; Aranda Valera C; de la Iglesia Salgado JL
Reumatol Clin; 2017; 13(3):150-155. PubMed ID: 27221374
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
[TBL] [Abstract][Full Text] [Related]
12. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of dense fine speckled pattern in anti-nuclear antibody test using indirect immunofluorescence method].
Kang SY; Lee WI
Korean J Lab Med; 2009 Apr; 29(2):145-51. PubMed ID: 19411782
[TBL] [Abstract][Full Text] [Related]
14. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
15. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
[TBL] [Abstract][Full Text] [Related]
16. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease.
Deane PM; Liard G; Siegel DM; Baum J
Pediatrics; 1995 Jun; 95(6):892-5. PubMed ID: 7761217
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura.
Altintas A; Ozel A; Okur N; Okur N; Cil T; Pasa S; Ayyildiz O
J Thromb Thrombolysis; 2007 Oct; 24(2):163-8. PubMed ID: 17436144
[TBL] [Abstract][Full Text] [Related]
18. Critical appraisal of the pattern of antinuclear antibodies (ANA) testing requested over a six month period at the "Escola Paulista de Medicina" (EPM), São Paulo.
Quaresma MR; Krauthamer A; Ferraz MB; Leser PG; Atra E
Rev Paul Med; 1993; 111(3):391-6. PubMed ID: 8108631
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey.
Sener AG; Afsar I; Demirci M
APMIS; 2014 Dec; 122(12):1167-70. PubMed ID: 24735346
[TBL] [Abstract][Full Text] [Related]
20. The antinuclear antibody test. When is a positive result clinically relevant?
Thomas C; Robinson JA
Postgrad Med; 1993 Aug; 94(2):55-8, 63, 66. PubMed ID: 8341626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
